Sign Up to like & get
recommendations!
2
Published in 2022 at "Issues in Mental Health Nursing"
DOI: 10.1080/01612840.2022.2149908
Abstract: Severe, ‘treatment-resistant’ depressions may respond to treatment with a classic monoamine oxidase inhibitor (MAOI) even when myriad trials with other antidepressant classes have failed (Bodkin & Dunlop, 2021). These drugs have a unique pharmacological profile…
read more here.
Keywords:
classic monoamine;
effect;
monoamine;
monoamine oxidase ... See more keywords